Pharmaceutical Industries

Sun Pharma Enters Global Licensing Agreement for Philogen’s Anti-Cancer Immunotherapy Fibromun

October 1, 2024

5:51 am

Sun Pharmaceutical Industries Ltd. announced on Monday that it has entered into a global licensing agreement with Swiss-Italian biotech firm Philogen to commercialize the specialty anti-cancer immunotherapy, Fibromun (L19TNF). This innovative treatment is currently under investigation in registration trials for the treatment of soft tissue

POST TAGS:

Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain

September 6, 2024

9:37 am

News Update

admin

Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, Sun Pharmaceutical Industries Limited, and includes its subsidiaries or associate companies) and Israel-based Moebius Medical Limited announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to MM-II (Large

POST TAGS:

Food Medical MEDICINES Moebius Medical Moshe Weinstein Pharmaceutical Industries Sun Pharma therapies

Sun Pharma Enters Global Licensing Agreement for Philogen’s Anti-Cancer Immunotherapy Fibromun

POST TAGS:

Sun Pharma and Moebius Medical Announce Fast Track Designation Granted for MM-II for the Treatment of Osteoarthritis Knee Pain

POST TAGS:

FIND US

ADDRESS

FOLLOW US ON SOCIAL MEDIA